Contact us

  • View funds and model portfolios

    Learn more about our investment products

    How to invest with us

  • Latest insights""Events and webinars""Vanguard outlook 2026""
  • Discover Vanguard 365""

    Learn and earn CPD

    In-depth research for advisers

    Tools and resources for advisers

  • About Vanguard""Contact us""Fraud prevention""

    Corporate reports

    • Contact us

    Global Equity Income Fund - GBP Acc (VAGEIGA)

    Available in other share classes
    Related Documents
    NAV Price ()
    —
    Number of stocks
    —
    —
    Risk Indicator
    —

    About this fund

    Fund objectives

    • The Fund seeks to provide an annual level of income (gross of fees) greater than that of the FTSE Developed Index (the “Index”) together with an increase in the value of investments over the long-term (more than 5 years).
    • The Fund will seek to achieve its investment objective by investing primarily in shares of companies which tend to pay out a larger amount of money as income (gross of fees) than an equivalent investment in the Index would pay out. Such companies may be located anywhere in the world. Under normal circumstances, at least 80% of the Fund's assets will normally be invested in shares.
    • The Fund is actively managed and uses a multi-manager structure with two investment advisers separately managing part of the Fund's assets. Each investment adviser uses their expertise to pick investments to achieve the Fund's objective.
    • The Fund generally invests in a diverse range of large and mid-size companies representing different economic sectors and industry groups. Companies are chosen because they consistently pay out money in the form of dividends from shares while also providing a reasonable increase in the value of investments over the long-term. The Fund's holdings will comprise a mix of investments in companies whose earnings are expected to grow faster than their peers in the market and those that are considered to have been undervalued by the market, providing exposure to a broad range of the world's developed and emerging markets. Emerging markets are countries that are progressing toward becoming advanced, usually shown by some development in financial markets, the existence of some form of stock exchange and a regulatory body.
    • The Fund may also have exposure to bonds and other similar securities, other collective investment schemes (which themselves invest in securities which are consistent with the Fund's objective), money market instruments, cash deposits and warrants. Money market instruments are investments usually issued by banks or governments that are a short term loan to the issuer by the buyer. Warrants provide the holder with the right, but not the obligation, to purchase a share at a fixed price or amount at a fixed time in the future.
    • The Fund attempts to remain fully invested and hold small amounts of cash except in extraordinary market, political or similar conditions where the Fund may temporarily depart from this investment policy to avoid losses.
    • The FTSE Developed Index (the “Index”) serves as a reference benchmark for performance comparison. Whilst the Fund may hold investments that are components of the Index, the Index is not considered during portfolio construction and the investment adviser will not manage the extent to which the Fund's investments differ from the Index.

    Fund facts

    Share class inception
    25 May 2016
    Minimum initial investment
    £100,000.00
    Investment structure
    UK OEIC
    Share Class Assets'
    Total Assets
    Strategy
    Active
    Asset Class
    Equity
    Domicile
    United Kingdom
    Dividend schedule
    —
    Tax status
    —
    Currency
    GBP
    Legal entity
    Vanguard® Investments Funds ICVC
    Investment manager

    Vanguard Quantitative Equity Group
    Wellington Management Company LLP

    Benchmark
    FTSE Developed Index

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Performance

    Risk and Volatility

    As at 30 Nov 2025

    Beta
    R²
    Annualized Tracking Error
    1 year
    3 years
    5 years

    Please note Beta and R-squared data will only display for funds with 3 full years of history.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Portfolio data

    Characteristics
    FundamentalsFundBenchmarkAs at
    Number of stocks 141 1,985 30 Nov 2025
    Median market capital 49.5 B 136.2 B 30 Nov 2025
    15.7 x 23.8 x 30 Nov 2025
    2.2 x 3.5 x 30 Nov 2025
    13.7% 19.2% 30 Nov 2025
    14.3% 21.6% 30 Nov 2025
    Portfolio turnover rate 61.8% — 31 Oct 2025

    Market allocation

    As at 30 Nov 2025

    CountryRegionFundBenchmarkVariance +/-
    United States of AmericaNorth America 43.23% 70.07% -26.84%
    United KingdomEurope 13.54% 3.66% 9.88%
    JapanPacific 8.11% 6.36% 1.75%
    FranceEurope 6.61% 2.54% 4.07%
    CanadaNorth America 5.52% 3.28% 2.24%
    SwitzerlandEurope 3.19% 2.30% 0.89%
    ItalyEurope 3.08% 0.84% 2.24%
    Hong KongPacific 2.87% 0.56% 2.31%
    NorwayEurope 2.75% 0.13% 2.62%
    GermanyEurope 2.63% 2.22% 0.41%
    SpainEurope 1.86% 0.89% 0.97%
    TaiwanEmerging Markets 1.41% 0.00% 1.41%
    IndiaEmerging Markets 1.17% 0.00% 1.17%
    South KoreaPacific 1.01% 1.50% -0.49%
    NetherlandsEurope 0.77% 1.12% -0.35%

    Holdings details

    As at 30 Sep 2025

    Holding name% of market valueSectorRegionMarket valueShares
    Merck & Co Inc 2.06453% Health Care US £12,209,109.44 195,836
    Bank of America Corp 1.89335% Financials US £11,196,781.91 292,182
    Johnson & Johnson 1.88933% Health Care US £11,172,991.28 81,122
    FinecoBank Banca Fineco SpA 1.88469% Financials IT £11,145,566.85 693,832
    Lamar Advertising Co 1.80609% Real Estate US £10,680,751.62 117,456
    Reckitt Benckiser Group PLC 1.76841% Consumer Staples GB £10,457,878.92 182,894
    BAE Systems PLC 1.72689% Industrials GB £10,212,392.92 495,988
    AstraZeneca PLC 1.71886% Health Care GB £10,164,885.28 90,904
    TotalEnergies SE 1.67164% Energy FR £9,885,608.53 218,952
    AIA Group Ltd 1.65217% Financials HK £9,770,513.76 1,370,930

    Total allocation percentages shown in the holdings details or the spreadsheet may not equal 100%, due to rounding or omission of cash and/or futures contracts.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Weighted equity exposures exclude any temporary cash investments and equity index derivatives.

    Prices and distribution

    Prices

    NAV Price (GBP)
    £288.95
    Change
    +£1.850.64%
    At closure 06 Jan 2026
    NAV 52-week high
    £288.95
    At closure 07 Jan 2026
    NAV 52-week low
    £224.89
    At closure 07 Jan 2026
    NAV 52-week difference
    £64.07
    Change
    +22.17%
    At closure 07 Jan 2026
    Historical Prices

    -

    Inception date

    25 May 2016

    Date NAV (GBP)
    06 Jan 2026 £288.9531
    05 Jan 2026 £287.1013
    02 Jan 2026 £286.0772
    31 Dec 2025 £284.9017
    30 Dec 2025 £285.8668
    29 Dec 2025 £285.2308
    24 Dec 2025 £284.9262
    23 Dec 2025 £284.9977
    22 Dec 2025 £284.6792
    19 Dec 2025 £284.9988

    Distribution history

    Distribution frequency

    —

    Historical performance 30 Nov 2025

    2.95%

    All dividends are reinvested for the "Accumulation" shares.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Purchase information

    Currency

    Base currency: GBP

    Fund codes

    • Bloomberg: VAGEIGA
    • Citi: N01Z
    • ISIN: GB00BZ82ZW98
    • MEX ID: VVXAD
    • SEDOL: BZ82ZW9

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    SEDOL and SEDOL Masterfile® are registered trademarks of the London Stock Exchange Group PLC. SEDOL data was extracted from the London Stock Exchange SEDOL Masterfile®.